Global Metformin Hydrochloride Market Growth 2025-2031

The global Metformin Hydrochloride market size is predicted to grow from US$ 403 million in 2025 to US$ 559 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.

The global key manufacturers of Metformin Hydrochloride include Keyuan Pharmaceutical, Aarti Drugs and Shijiazhuang Polee, etc, top 3 manufacturers hold a share approximately 36%. Keyuan Pharmaceutical is the world's largest Metformin Hydrochloride manufacturer, with a market share of more than 14%. India, China and Europe are the major Metformin Hydrochloride market, they have a market share of more than 68%. India is the largest market with a share of 46%. In terms of product type, Metformin HCL is the largest market segment with a share of more than 82%. In terms of applications, Metformin Hydrochloride Tablets is the largest downstream segment, with a market share of about 72%.

LP Information, Inc. (LPI) ' newest research report, the “Metformin Hydrochloride Industry Forecast” looks at past sales and reviews total world Metformin Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Metformin Hydrochloride sales for 2025 through 2031. With Metformin Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metformin Hydrochloride industry.

This Insight Report provides a comprehensive analysis of the global Metformin Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metformin Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metformin Hydrochloride market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metformin Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metformin Hydrochloride.

This report presents a comprehensive overview, market shares, and growth opportunities of Metformin Hydrochloride market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Metformin HCL
Metformin DC

Segmentation by Application:
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Metformin Hydrochloride market?

What factors are driving Metformin Hydrochloride market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Metformin Hydrochloride market opportunities vary by end market size?

How does Metformin Hydrochloride break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.